Global Atorvastatin Calcium Strategic Research Report 2021
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Atorvastatin calcium is [R-(R*, R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1Hpyrrole-1-heptanoic acid, calcium salt (2:1)trihydrate. The empirical formula of atorvastatin calcium is(C33H34FN2O5)2Ca•3H2O and its molecular weight is 1209.42.
Atorvastatin calcium is a white to off-white crystalline powder that is insoluble in aqueous solutions of pH 4and below. Atorvastatin calcium is very slightly soluble in distilled water, pH 7.4 phosphate buffer, and acetonitrile; slightly soluble in ethanol; and freely soluble in methanol.
The major players in global market include
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Atorvastatin Calcium in these regions, from 2013 to 2024 (forecast), covering
North America (United States,Canada, Mexico)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Other Regions )
Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
South America (Brazil. Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, U.A.E, Other Regions)
On the basis of product, the Atorvastatin Calcium market is primarily split into
Chemical Synthesis
Biocatalysis
Others
On the basis on the end users/applications, this report covers
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
Table of Contents
1 Target Product and Background
1.1 Product Overview Atorvastatin Calcium
1.2 Research Method
1.3 Data Source
1.4 Project Cycle
1.5 Forecast Data Base & Factor
1.6 Macroeconomic Development Trends
1.7 Impact of COVID-19 on the Economy and Atorvastatin Calcium Industry
1.7.1 Post-COVID-19 era
1.7.2 The Impact of COVID-19 on Atorvastatin Calcium Industry
2 Manufacturers Competitive Analysis of Major Players
2.1 Competitive Segmentation Analysis of Key Players
2.2 2016-2021 Key Players Sales Volume and Market Positions
2.3 Key Players Revenue and Market Positions
3 Atorvastatin Calcium Sales Segment Analysis by Type
3.1 Overview
3.1.1 Chemical Synthesis
3.1.2 Biocatalysis
3.1.3 Others
3.2 2016-2027 Global Atorvastatin Calcium Sales Volume Segment Analysis by Type
3.3 2016-2027 Global Atorvastatin Calcium Revenue Segment Analysis by Type
4 Atorvastatin Calcium Sales Segment Analysis End User
4.1 Introduction
4.1.1 Tablet (Including Dispersible Tablet and General Tablet)
4.1.2 Capsule
4.2 2016-2027 Global Atorvastatin Calcium Sales Volume Segment Analysis by End User
4.3 2016-2027 Global Atorvastatin Calcium Revenue Segment Analysis by End User
5 Atorvastatin Calcium Market Analysis, by Region by Country
5.1 Global Atorvastatin Calcium Market Size and Regional Analysis
5.2 Global Atorvastatin Calcium Retrospective Market Scenario in Revenue by Region: 2016-2021
5.3 North America Market Size and Regional Analysis
5.3.1 North America Sales by Country
5.3.2 North America Atorvastatin Calcium Revenue by Country
5.4 Europe Market Size and Regional Analysis
5.4.1 Europe Atorvastatin Calcium Sales by Country
5.4.2 Europe Atorvastatin Calcium Revenue by Country
5.5 Asia Pacific Market Size and Regional Analysis
5.5.1 Asia Pacific Atorvastatin Calcium Sales by Region
5.5.2 Asia Pacific Atorvastatin Calcium Revenue by Region
5.6 South America Market Size and Regional Analysis
5.6.1 South America Atorvastatin Calcium Sales by Country
5.6.2 South America Atorvastatin Calcium Revenue by Country
5.7 Middle East and Africa Market Size and Regional Analysis
5.7.1 Middle East and Africa Atorvastatin Calcium Sales by Country
5.7.2 Middle East and Africa Atorvastatin Calcium Revenue by Country
6 Atorvastatin Calcium SWOT and Driving Factor Analysis
6.1 SWOT Analysis
6.2 Marketing Strategy
6.3 Technology Driven Market
6.4 Atorvastatin Calcium Growth Drivers
6.5 Atorvastatin Calcium Market Challenges
6.6 Atorvastatin Calcium Market Restraints
7 Atorvastatin CalciumRaw Material Supply and Industry Chain Analysis
7.1 Atorvastatin Calcium Key Raw Material Supply
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Atorvastatin Calcium Industrial Chain Analysis and Reconstruction
8 Global Atorvastatin Calcium Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Corporate Outline
8.1.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.1.3 Pfizer Atorvastatin Calcium Key Product Overview
8.1.4 Atorvastatin Calcium Key Product Overview
8.1.5 Pfizer Business Segmentation SWOT Analysis
8.2 DSM Sinochem Pharmaceuticals
8.2.1 DSM Sinochem Pharmaceuticals Corporate Outline
8.2.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Key Product Overview
8.2.4 Atorvastatin Calcium Key Product Overview
8.2.15DSM Sinochem Pharmaceuticals Business Segmentation SWOT Analysis
8.3 Cadila Pharmaceuticals
8.3.1 Cadila Pharmaceuticals Corporate Outline
8.3.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.3.3 Kremers Urban Pharmaceuticals Inc. Atorvastatin Calcium Key Product Overview
8.3.4 Atorvastatin Calcium Key Product Overview
8.3.5 Cadila Pharmaceuticals Business Segmentation SWOT Analysis
8.4 Sun Pharmaceutical Industries
8.4.1 Sun Pharmaceutical Industries Corporate Outline
8.4.1 Sun Pharmaceutical Industries Corporate Outline
8.4.3 Topfond Atorvastatin Calcium Key Product Overview
8.4.4 Atorvastatin Calcium Key Product Overview
8.4.5 Sun Pharmaceutical Industries Business Segmentation SWOT Analysis
8.5 Dr. Reddy’s
8.5.1 Dr. Reddy’s Corporate Outline
8.5.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.5.3 Atorvastatin Calcium Key Product Overview
8.5.4 Atorvastatin Calcium Key Product Overview
8.5.5 Dr. Reddy’s Business Segmentation SWOT Analysis
8.6 Morepen
8.6.1 Morepen Corporate Outline
8.6.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.6.3 Atorvastatin Calcium Key Product Overview
8.6.4 Atorvastatin Calcium Key Product Overview
8.6.5 Morepen Business Segmentation SWOT Analysis
8.7 Teva Pharmaceutical Industries
8.7.1 Teva Pharmaceutical Industries Corporate Outline
8.7.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.7.3 Atorvastatin Calcium Key Product Overview
8.7.4 Atorvastatin Calcium Key Product Overview
8.7.5 Teva Pharmaceutical Industries Business Segmentation SWOT Analysis
8.8 Apotex Pharmachem
8.8.1 Apotex Pharmachem Corporate Outline
8.8.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.8.3 Atorvastatin Calcium Key Product Overview
8.8.4 Atorvastatin Calcium Key Product Overview
8.8.5 Apotex Pharmachem Business Segmentation SWOT Analysis
8.9 Sandoz Inc
8.9.1 Sandoz Inc Corporate Outline
8.9.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.9.3 Atorvastatin Calcium Key Product Overview
8.9.4 Atorvastatin Calcium Key Product Overview
8.9.5 Sandoz Inc Business Segmentation SWOT Analysis
8.10 Mylan Pharmaceuticals Inc.
8.10.1 Mylan Pharmaceuticals Inc. Corporate Outline
8.10.2 Breakdown Sales Volume, Revenue (US$ Million), Price and Gross Margin (2018-2021)
8.10.3 Atorvastatin Calcium Key Product Overview
8.10.4 Atorvastatin Calcium Key Product Overview
8.10.5 Mylan Pharmaceuticals Inc. Business Segmentation SWOT Analysis
8.11 Kremers Urban Pharmaceuticals Inc.
8.12 ScieGen Pharmaceuticals, Inc.
8.13 Zheijang Neo-Dankon Pharmaceutical
8.14 Ningbo Menovo Pharmaceuticals Group
8.15 Jialin Pharmaceutical
8.16 Topfond
8.17 Zhejiang Hisun Pharmacutical
8.18 Zhejiang Hongyuan Pharmaceutical
8.19 Hubei Yitai Pharmaceutical
8.20 Jiangsu Hengrui Medicine
9 Atorvastatin Calcium Report Conclusion and Strategy
10 Appendix
10.1 Order and After-sales Service
10.2 Author List
10.3 Disclaimer
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project. We will go all out and never give up. ASSO regards each other's excellence as the purpose of our service. ASSO's services involve regional analysis, market data, player share, market decision-making, marketing and product positioning
– Allen King
Leave a comment
All fields marked with an asterisk (*) are required